Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avicanna Inc (AVCN.TO)

Avicanna Inc (AVCN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,468
  • Shares Outstanding, K 106,906
  • Annual Sales, $ 16,791 K
  • Annual Income, $ -8,743 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.15
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book 895.99
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.03 on 08/14/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2700 +7.41%
on 11/01/24
0.3650 -20.55%
on 10/09/24
-0.0400 (-12.12%)
since 10/07/24
3-Month
0.2700 +7.41%
on 11/01/24
0.4500 -35.56%
on 09/06/24
-0.0200 (-6.45%)
since 08/07/24
52-Week
0.2000 +45.00%
on 06/21/24
0.6000 -51.67%
on 03/18/24
-0.1200 (-29.27%)
since 11/07/23

Most Recent Stories

More News
Avicanna Announces Closing of Non-Brokered Private Placement

AVCN.TO : 0.2900 (+1.75%)
AVCNF : 0.1985 (-0.55%)
Stocks in play: Avicanna Inc.

Announced it has cleared and fully repaid $1,445,000 that was owed under the Debentures of August 2, ...

AVCN.TO : 0.2900 (+1.75%)
Stocks in play: Avicanna Inc.

Announced the United States Patent and Trademark Office issuance of the Patent covering Avicanna’s SEDDS ...

AVCN.TO : 0.2900 (+1.75%)
Stocks in play: Avicanna Inc.

Announced that the Company will host a medical symposium entitled “Cannabinoid-based Medicine in the ...

AVCN.TO : 0.2900 (+1.75%)
Stocks in play: Avicanna Inc.

Announced a corporate update and preliminary financial results of Q2-2023. Revenues were approximately ...

AVCN.TO : 0.2900 (+1.75%)
Stocks in play: Avicanna Inc

Announced the execution of the definitive Asset Purchase Agreement between Shoppers Drug Mart and Avicanna ...

AVCN.TO : 0.2900 (+1.75%)
Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals

Psilly™ branded functional fungi-based products will be developed by Avicanna utilizing Avicanna’s proprietary delivery systems and scientific platform ...

AVCN.TO : 0.2900 (+1.75%)
AVCNF : 0.1985 (-0.55%)
Avicanna Announces Date of Upcoming Annual General and Special Meeting of Shareholders

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.2900 (+1.75%)
AVCNF : 0.1985 (-0.55%)
Stocks in play: Avicanna Inc.

Has completed its first commercial export of its evidence-based derma-cosmetic line Pura H&W into the ...

AVCN.TO : 0.2900 (+1.75%)
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

The company is maintaining operations and its shares in its primary Majority-Owned Subsidiary, Santa Marta Golden Hemp, also based in Santa Marta Colombia...

AVCN.TO : 0.2900 (+1.75%)
AVCNF : 0.1985 (-0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid...

See More

Key Turning Points

3rd Resistance Point 0.3033
2nd Resistance Point 0.2967
1st Resistance Point 0.2933
Last Price 0.2900
1st Support Level 0.2833
2nd Support Level 0.2767
3rd Support Level 0.2733

See More

52-Week High 0.6000
Fibonacci 61.8% 0.4472
Fibonacci 50% 0.4000
Fibonacci 38.2% 0.3528
Last Price 0.2900
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar